US Patent Issued to Novo Nordisk on March 11 for "Insulin titration algorithm based on patient profile" (American, Danish Inventors)

ALEXANDRIA, Va., March 12 -- United States Patent no. 12,249,425, issued on March 11, was assigned to Novo Nordisk A/S (Bagsvaerd, Denmark).

"Insulin titration algorithm based on patient profile" was invented by Oleksandr Shvets (Yardley, Pa.), Tinna Bjoerk Aradottir (Copenhagen, Denmark), Thomas Dedenroth Miller (Seattle) and Anuar Imanbayev (Seattle).

According to the abstract* released by the U.S. Patent & Trademark Office: "A device, system and method is provided for predicting risk of hypoglycemia and adjusting an insulin medicament dose size for a subject being on pen based multi-daily injections. A first algorithm is provided for computing a first insulin dose size based on a plurality of timestamped blood glucose (BG) measurements...